Stanford's Virtual Biotech System Designs Lung Cancer Therapy Validated by Merck

Stanford, Sunday, 9 August 2026.
Stanford scaled 37,000 collaborative AI agents to autonomously design a lung cancer therapeutic strategy, which pharmaceutical giant Merck subsequently validated in real-world clinical developments.